Selecting anti-epileptic drugs: a pediatric epileptologist's view, a computer's view
Article first published online: 23 SEP 2012
© 2012 John Wiley & Sons A/S
Acta Neurologica Scandinavica
Volume 127, Issue 3, pages 208–215, March 2013
How to Cite
Selecting anti-epileptic drugs: a pediatric epileptologist's view, a computer's view. Acta Neurol Scand: DOI: 10.1111/ane.12002. © 2012 John Wiley & Sons A/S., , , , , .
- Issue published online: 15 FEB 2013
- Article first published online: 23 SEP 2012
- Manuscript Accepted: 25 JUL 2012
- pediatric neurology;
- decision support;
- anti-epileptic drug selection;
- artificial intelligence
To identify which clinical characteristics are important to include in clinical decision support systems developed for Antiepileptic Drug (AEDs) selection.
Twenty-three epileptologists from the Childhood Absence Epilepsy network completed a survey related to AED selection. Using cluster analysis their responses where classified into subject matter groups and weighted for importance.
Five distinct subject matter groups were identified and their relative weighting for importance were determined: disease characteristics (weight 4.8 ± 0.049), drug toxicities (3.82 ± 0.098), medical history (3.12 ± 0.102), systemic characteristics (2.57 ± 0.048) and genetic characteristics (1.08 ± 0.046).
Research about prescribing patterns exists but research on how such data can be used to train advanced technology is novel. As machine learning algorithms becomes more and more prevalent in clinical decisions support systems, developing methods for determining which data should be part of those algorithms is equally important.